Express Pharma June 16-30, 2019
India's Foremost Pharma & Biotech Magazine ~ Digital Era of Drug Development
Author
Biocon’s biologics facilities in Bengaluru received GMP compliance certificate from EMA
The certification will enable the company to continue addressing the growing needs of patients in the EU markets
Univercells granted $14.3 mn to deliver affordable measles and rubella vaccines
The grant has been given by the Bill and Melinda Gates Foundation to increase the availability of measles and rubella (M&R)…
Sun Pharma announces Late-Breaking Phase 2 data showing potential of ILUMYA (tildrakizumab-asmn)
The drug has been designed to improve joint and skin symptoms of Psoriatic Arthritis. Over 71 per cent of patients treated with…
DRL to sell neurology branded products to Upsher-Smith Laboratories
Dr Reddy’s would sell its US and select territory rights for ZEMBRACE SYMTOUCH and TOSYMRATM, which are commercialized through its…
‘The Future of Supply Chain Management’ by OPPI
The Organisation of Pharmaceutical Producers of India (OPPI), in collaboration with Indian Pharmaceutical Alliance and Indian Drug…
OPPI to host an event on ‘The Future of Supply Chain Management’
The event endeavours to explore the challenges of supply chain management through discussions on manufacturing, warehousing,…
Wockhardt’s bioequivalence centre at Aurangabad receives zero observations from US FDA
During the inspection, bioanalytical and quality systems of bioequivalence studies of Tamsulosin 0.4 mg capsules and Metoprolol ER…
Neelikon conferred with the ‘SME Elite 50’ award
The award is a recognition as one of the Best Entrepreneur in the SME sector in India
Sobi buys rare-disease drug emapalumab, zooms in on hematology and immunology
The drug-maker said that it would buy a newly established company owning the drug candidate for the treatment of primary…